Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report
With the advent of immunotherapies, the field of cancer therapy has been revived with new hope, especially for cancers with dismal prognoses, such as the glioblastoma multiforme (GBM). Currently, immunotherapies should potentiate the host’s own antitumor immune response against cancer cells, but it...
Main Authors: | Navid Sobhani, Victoria Bouchè, Giovanni Aldegheri, Andrea Rocca, Alberto D’Angelo, Fabiola Giudici, Cristina Bottin, Carmine Antonio Donofrio, Maurizio Pinamonti, Benvenuto Ferrari, Stefano Panni, Marika Cominetti, Jahard Aliaga, Marco Ungari, Antonio Fioravanti, Fabrizio Zanconati, Daniele Generali |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/2/311 |
Similar Items
-
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study
by: Andrea Rocca, et al.
Published: (2024-03-01) -
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
by: Navid Sobhani, et al.
Published: (2018-07-01) -
A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection
by: Marina Bortul, et al.
Published: (2023-05-01) -
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair
by: Monica Ganzinelli, et al.
Published: (2023-08-01) -
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2− Breast Cancer Based on a Window of Opportunity Study
by: Alberto D’Angelo, et al.
Published: (2022-09-01)